These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7956730)

  • 1. Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats.
    Nadai M; Hasegawa T; Wang L; Tagaya O; Nabeshima T
    Drug Metab Dispos; 1994; 22(4):561-5. PubMed ID: 7956730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and renal handling of enprofylline in pregnant rats.
    Muraoka I; Hasegawa T; Nadai M; Kato K; Nabeshima T
    Drug Metab Dispos; 1992; 20(5):653-7. PubMed ID: 1358568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
    Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
    Drug Metab Dispos; 1993; 21(4):611-6. PubMed ID: 8104119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
    Yamazaki M; Kobayashi K; Sugiyama Y
    Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age on the disposition and renal handling of enprofylline in rats.
    Muraoka I; Hasegawa T; Nadai M; Wang L; Tagaya O; Nabeshima T
    J Pharm Pharmacol; 1994 Mar; 46(3):230-4. PubMed ID: 8027934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.
    Muraoka I; Hasegawa T; Nadai M; Wang L; Haghgoo S; Tagaya O; Nabeshima T
    Antimicrob Agents Chemother; 1995 Jan; 39(1):70-4. PubMed ID: 7695332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
    Yamazaki M; Kobayashi K; Sugiyama Y
    Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion of copper, manganese, and horseradish peroxidase in Eisai hyperbilirubinemic mutant rats (EHBRs) with defective biliary excretion of glutathione.
    Sugawara N; Lai Y; Yuasa M; Dhar SK; Arizono K
    Biol Trace Elem Res; 1996; 55(1-2):181-9. PubMed ID: 8971365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of N-benzoyl-beta-alanine, a new nephroprotective drug, on the distribution and renal excretion of enprofylline in rats.
    Wang L; Hasegawa T; Nadai M; Nabeshima T
    J Pharm Pharmacol; 1993 Jul; 45(7):622-6. PubMed ID: 8105057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives.
    Tsunekawa Y; Hasegawa T; Nadai M; Takagi K; Nabeshima T
    J Pharm Pharmacol; 1992 Jul; 44(7):594-9. PubMed ID: 1357141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats.
    Nadai M; Hasegawa T; Wang L; Haghgoo S; Nabeshima T; Kato N
    Biol Pharm Bull; 1995 Aug; 18(8):1089-93. PubMed ID: 8535402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats.
    Lu SC; Cai J; Kuhlenkamp J; Sun WM; Takikawa H; Takenaka O; Horie T; Yi J; Kaplowitz N
    Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of enprofylline and its renal handling in rats.
    Nadai M; Hasegawa T; Muraoka I; Takagi K; Nabeshima T
    J Pharm Sci; 1991 Jul; 80(7):648-52. PubMed ID: 1941561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
    Sathirakul K; Suzuki H; Yasuda K; Hanano M; Tagaya O; Horie T; Sugiyama Y
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
    Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
    Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased pancreatic exocrine function in the mutant Eisai hyperbilirubinemic rat (EHBR).
    Inagaki T; Hoshino M; Ohara H; Yamada T; Ogasawara T; Shimizu H; Itoh M
    Pancreas; 1999 Mar; 18(2):172-9. PubMed ID: 10090415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diabetes on disposition and renal handling of cefazolin in rats.
    Nadai M; Yoshizumi H; Kuzuya T; Hasegawa T; Johno I; Kitazawa S
    Drug Metab Dispos; 1990; 18(5):565-70. PubMed ID: 1981703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats.
    Han YH; Kato Y; Sugiyama Y
    J Pharmacol Exp Ther; 1999 Oct; 291(1):204-12. PubMed ID: 10490906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.
    Shimizu A; Miyoshi M; Sugie M; Ueyama J; Yamaguchi T; Sasaki T; Takagi K; Jin M; Miyamoto K; Tsuji A; Hasegawa T
    Eur J Pharmacol; 2004 Oct; 501(1-3):151-9. PubMed ID: 15464074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probenecid on enprofylline kinetics in man.
    Borgå O; Larsson R; Lunell E
    Eur J Clin Pharmacol; 1986; 30(2):221-3. PubMed ID: 3709650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.